Literature DB >> 20352238

Should all patients referred for magnetic resonance imaging scans of their internal auditory meatus be followed up in ENT clinics?

Harry R F Powell1, Dennis I Choa.   

Abstract

Magnetic resonance imaging (MRI) is recognised as the "Gold Standard" investigation for symptoms pertaining to the inner ear and detection of retro-cochlear pathology. There is still no accurate clinical predictor for cerebellopontine angle lesions and increasingly more normal scans are being performed. With constantly increasing demands on ENT outpatient clinics, our aim was to investigate whether all patients referred for MRI of their internal auditory meatus (IAM) require follow-up in ENT clinics. A retrospective study was carried out in a tertiary referral centre referring patients for MRI IAM from ENT clinics and neurotology clinics on 153 patients referred for MRI IAM performed over a 4-month period. The MRI reports and the case notes of the patients were reviewed. MRI results and patient symptoms with patient follow-up schedule and follow-up situation for at least 6 months post-scan were compared. There were two patient groups, those referred from main outpatients (81) and those referred by the audiological physicians (72). Of the total number of scans, 101 were reported as normal, 45 had incidental findings, and 7 showed pathology of the cerebellopontine angle. The presenting complaints of the patients, the scan results and the follow-up since were compared. Six months later 63% of those referred from outpatients were no longer being followed up in clinic. We suggest that 56.8% of patients referred for MRI IAM do not require ENT follow-up. Their symptoms and concerns could be dealt with at the first consultation where onward referral could be made if necessary. Once checked by the requesting clinician, uncomplicated scan results could be sent to the patients and general practitioners by post or email. This would reduce the burden on general otolaryngology outpatient clinics and improve resource utilisation.

Entities:  

Mesh:

Year:  2010        PMID: 20352238     DOI: 10.1007/s00405-010-1237-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  9 in total

1.  Magnetic resonance imaging scans for vestibulocochlear nerve tumours: what is actually found?

Authors:  E J Chisholm; L Savy; M Geyer; D Choa
Journal:  J Laryngol Otol       Date:  2006-09-25       Impact factor: 1.469

2.  Gadolinium. The new gold standard for diagnosing cerebellopontine angle tumors.

Authors:  J D Sidman; V N Carrasco; R A Whaley; H C Pillsbury
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-10

3.  MRI in the detection of acoustic neuromas--a suggested protocol for screening.

Authors:  I J Sheppard; C A Milford; P Anslow
Journal:  Clin Otolaryngol Allied Sci       Date:  1996-08

4.  The incidence of symptoms consistent with cerebellopontine angle lesions in a general ENT out-patient clinic.

Authors:  J P Harcourt; S Vijaya-Sekaran; E Loney; P Lennox
Journal:  J Laryngol Otol       Date:  1999-06       Impact factor: 1.469

5.  Hearing threshold difference between ears and risk of acoustic tumor.

Authors:  C A Mangham
Journal:  Otolaryngol Head Neck Surg       Date:  1991-12       Impact factor: 3.497

6.  Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifier.

Authors:  S A R Nouraei; Q J M Huys; P Chatrath; J Powles; J P Harcourt
Journal:  Clin Otolaryngol       Date:  2007-08       Impact factor: 2.597

7.  MRI as a single screening procedure for acoustic neuroma: a cost effective protocol.

Authors:  A K Robson; S E Leighton; P Anslow; C A Milford
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

8.  Referral patterns in vestibular schwannomas.

Authors:  D A Moffat; D G Hardy; R M Irving; L Viani; G J Beynon; D M Baguley
Journal:  Clin Otolaryngol Allied Sci       Date:  1995-02

9.  Magnetic resonance imaging screening for vestibular schwannoma: analysis of published protocols.

Authors:  R J Obholzer; P A Rea; J P Harcourt
Journal:  J Laryngol Otol       Date:  2004-05       Impact factor: 1.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.